Evaluation of the Effectiveness of Acceptance and Commitment Therapy for General Mental Health Concerns in HIV-Positive Men
Overview
- Phase
- Not Applicable
- Intervention
- Acceptance and commitment therapy
- Conditions
- Stress
- Sponsor
- University of Alabama at Birmingham
- Enrollment
- 1
- Locations
- 1
- Primary Endpoint
- Patient Health Questionnaire-9 Screener
- Status
- Terminated
- Last Updated
- 12 days ago
Overview
Brief Summary
The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.
Detailed Description
The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.
Investigators
Nicholas C. Borgogna
Assistant Professor
University of Alabama at Birmingham
Eligibility Criteria
Inclusion Criteria
- •identify as a man
- •be at least 18 years old
- •has been diagnosed with HIV by a healthcare professional
Exclusion Criteria
- •has engaged in self-harm within the last three months
- •has attempted suicide within the last year
- •has had an active plan to attempt suicide within the last 30 days
- •is currently diagnosed with any eating disorder
- •has experienced hallucinations or delusions within the last 30 days
- •has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)
Arms & Interventions
Acceptance and commitment therapy
Trial of acceptance and commitment therapy for hiv-positive men.
Intervention: Acceptance and commitment therapy
Outcomes
Primary Outcomes
Patient Health Questionnaire-9 Screener
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of depressive symptoms
PTSD Checklist-5
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of post-traumatic stress symptoms
Yale-Brown Obsessive Compulsive Scale
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of obsessive-compulsive disorder symptoms
Alcohol Use Disorders Identification Test
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of alcohol use
HIV stigma scale
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of facets of stigma experienced by individuals with HIV
Internalized homophobia scale
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of internalized homophobia
Brief pornography screen
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of concerning pornography use
Life Quality Scale
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of life quality
Experiential Avoidance Rating Scale
Time Frame: Administered at baseline, every two weeks (every second therapy session) during intervention, and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of experiential avoidance
National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of drug use
High risk sexual behaviors
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
* Frequency of sex with penetration * Frequency of condom use * Frequency of oral sex * Frequency of sexual partners
Generalized Anxiety Disorder-7 Screener
Time Frame: Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of anxiety symptoms
PSYFLEX
Time Frame: Administered at baseline, every two weeks (every second therapy session) during intervention, and immediately after final intervention session (8th/final session; each session is 1 hour)
Measure of psychological flexibility
Secondary Outcomes
- Therapeutic Alliance Scale(Administered immediately after final intervention session (8th/final session; each session is 1 hour))